Paper36600320
MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K/AKT signaling.
Zhu Q and 9 others. Biomark Res, 2023. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K/AKT signaling. Papers, record 36600320. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36600320
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K/AKT signaling.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23102669 | MicroRNA and cancer. | Mol Oncol | 2012 | https://conductscience.org/library/papers/23102669 | PubMed |
| 2 | 19966785 | Rab27a and Rab27b control different steps of the exosome secretion pathway. | Nat Cell Biol | 2010 | https://conductscience.org/library/papers/19966785 | PubMed |
| 3 | 29893409 | MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B. | J Cell Physiol | 2018 | https://conductscience.org/library/papers/29893409 | PubMed |
| 4 | 31660076 | Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation. | Theranostics | 2019 | https://conductscience.org/library/papers/31660076 | PubMed |
| 5 | 35073459 | LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability. | Clin Transl Med | 2022 | https://conductscience.org/library/papers/35073459 | PubMed |
| 6 | 19796752 | Molecular predictive and prognostic markers in non-small-cell lung cancer. | Lancet Oncol | 2009 | https://conductscience.org/library/papers/19796752 | PubMed |
| 7 | 36371494 | RAB27A promotes the proliferation and invasion of colorectal cancer cells. | Sci Rep | 2022 | https://conductscience.org/library/papers/36371494 | PubMed |
| 8 | 32937886 | Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32937886 | PubMed |
| 9 | 33213490 | Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/33213490 | PubMed |
| 10 | 18452692 | Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. | Mayo Clin Proc | 2008 | https://conductscience.org/library/papers/18452692 | PubMed |
| 11 | 32355248 | Rab27a plays a dual role in metastatic propensity of pancreatic cancer. | Sci Rep | 2020 | https://conductscience.org/library/papers/32355248 | PubMed |
| 12 | 31691562 | Reflecting Size Differences of Exosomes by Using the Combination of Membrane-Targeting Viscosity Probe and Fluorescence Lifetime Imaging Microscopy. | Anal Chem | 2019 | https://conductscience.org/library/papers/31691562 | PubMed |
| 13 | 25985394 | Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. | Nat Cell Biol | 2015 | https://conductscience.org/library/papers/25985394 | PubMed |
| 14 | 30425059 | miR-146a Controls Immune Response in the Melanoma Microenvironment. | Cancer Res | 2019 | https://conductscience.org/library/papers/30425059 | PubMed |
| 15 | 30355233 | miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy. | Circ Res | 2018 | https://conductscience.org/library/papers/30355233 | PubMed |
| 16 | 32897692 | Generation of Small RNA-Modulated Exosome Mimetics for Bone Regeneration. | ACS Nano | 2020 | https://conductscience.org/library/papers/32897692 | PubMed |
| 17 | 35300565 | MicroRNA miR-124-3p suppresses proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma via ARRDC1 (arrestin domain containing 1). | Bioengineered | 2022 | https://conductscience.org/library/papers/35300565 | PubMed |
| 18 | 26707908 | MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3. | Oncol Rep | 2016 | https://conductscience.org/library/papers/26707908 | PubMed |
| 19 | 31324812 | circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. | Nat Commun | 2019 | https://conductscience.org/library/papers/31324812 | PubMed |
| 20 | 33416105 | Downregulation of hsa_circ_0026123 suppresses ovarian cancer cell metastasis and proliferation through the miR‑124‑3p/EZH2 signaling pathway. | Int J Mol Med | 2021 | https://conductscience.org/library/papers/33416105 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42724932 | miR-27b-5p targets RAB27A to regulate exosome secretion and migration of pancreatic cancer cells. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724932 | PubMed |
| 41935350 | MiR-124-3p Suppresses Glioma Cells Progression by Targeting STAT3/NAMPT and Inhibiting AKT/ERK Signaling. | Curr Cancer Drug Targets | 2026 | https://conductscience.org/library/papers/41935350 | PubMed |
| 41891957 | Multifaceted roles of miR‑124 in cancer: Molecular mechanisms and clinical prospects (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/41891957 | PubMed |
| 41756253 | RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/41756253 | PubMed |
| 41737608 | Long non-coding RNAs in the exosomal network: dual roles and clinical implications in cancer. | Anim Cells Syst (Seoul) | 2026 | https://conductscience.org/library/papers/41737608 | PubMed |
| 41281941 | Circular RNA-based liquid biopsy: a promising approach for monitoring drug resistance in cancer. | Cancer Drug Resist | 2025 | https://conductscience.org/library/papers/41281941 | PubMed |
| 40625748 | Serum exosomal microRNA profiling reveals a down-regulation of hsa-miR-124-3p in patients with severe acne. | Front Immunol | 2025 | https://conductscience.org/library/papers/40625748 | PubMed |
| 40618273 | MicroRNA and Alzheimer's disease: Diagnostic biomarkers and potential therapeutic targets. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/40618273 | PubMed |
| 40576131 | SLC7A1, SGK1 and HMGB2 are overexpressed in cervical cancer tissues and the miR‑23b‑3p/HMGB2 axis regulates cell migration and invasion. | Mol Med Rep | 2025 | https://conductscience.org/library/papers/40576131 | PubMed |
| 40034961 | Evaluation of PI3K Levels and miRNA124-5p Expression Levels in Serum Samples from Patients With Lung Cancer. | Cancer Diagn Progn | 2025 | https://conductscience.org/library/papers/40034961 | PubMed |
| 40028322 | Exosome tropism and various pathways in lung cancer metastasis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40028322 | PubMed |
| 39968497 | Exosomes: a double-edged sword in cancer immunotherapy. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/39968497 | PubMed |
| 39720352 | Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applications. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/39720352 | PubMed |
| 39712244 | Identification of genetic associations between acute myocardial infarction and non-small cell lung cancer. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/39712244 | PubMed |
| 39460871 | MiR-124-3p inhibits cell stemness in glioblastoma via targeting EPHA2 through ALKBH5-mediated m6A modification. | Hum Cell | 2024 | https://conductscience.org/library/papers/39460871 | PubMed |
| 39400677 | Exosomal microRNA as a key regulator of PI3K/AKT pathways in human tumors. | Med Oncol | 2024 | https://conductscience.org/library/papers/39400677 | PubMed |
| 39296640 | Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/39296640 | PubMed |
| 39273053 | The Role of circHIPK3 in Tumorigenesis and Its Potential as a Biomarker in Lung Cancer. | Cells | 2024 | https://conductscience.org/library/papers/39273053 | PubMed |
| 38791918 | Genome-Wide Methylation Analysis in Two Wild-Type Non-Small Cell Lung Cancer Subgroups with Negative and High PD-L1 Expression. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38791918 | PubMed |
| 38778340 | Extracellular vesicles promote migration despite BRAF inhibitor treatment in malignant melanoma cells. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/38778340 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36600320
GET https://conductscience.org/api/papers/v1/36600320/references?page=2